|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01652 FUSEN PHARM
Nominal 
0.810 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 196,322 | -41.647% | 336,437 | 165,611 | 214,212 | 247,502 |
| Cost of Sales | (90,450) | -42.505% | (157,319) | (85,878) | (95,980) | (114,671) |
| Gross Profit | 105,872 | -40.893% | 179,118 | 79,733 | 118,232 | 132,831 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (1,430) | -89.535% | (13,664) | (4,560) | 9,811 | 12,231 | |
| Profit / (Loss) before Taxation | (45,325) | -- | 22,896 | (7,313) | 50,797 | 41,877 | |
| Taxation | 8,376 | -- | (6,449) | 236 | (6,988) | (8,447) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 8 | -11.111% | 9 | 40 | 110 | 1,504 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (36,941) | -- | 16,456 | (7,037) | 43,919 | 34,934 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 7,356 | 228.246% | 2,241 | 9,931 | 5,862 | 4,034 |
| Depreciation & Amortisation | -- | -- | -- | -- | -- | -- |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | -5.000 | -- | 2.000 | -1.000 | 6.000 | 4.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.570 | 0.450 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | 9.500% | 11.250% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.694 | -- | 0.820 | 0.851 | 0.906 | 0.851 |
| Remarks: | Real time quote last updated: 24/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -36,941,000 |
| %Change | -- |
| EPS / (LPS) | RMB -0.050 |
| NBV Per Share (¥) | RMB 0.694 |